1 Critical Care
Medicine - Most Popular Articles by Fielding-Singh, Vikram;
Matthay, Michael A.; Calfee, Carolyn S.
/ 7d // keep unread // hide
Objectives:
Despite decades of research, the acute respiratory distress syndrome remains
associated with significant morbidity and mortality. This Concise Definitive
Review provides a practical and evidence-based summary of treatments in
addition to low tidal volume ventilation and their role in the management of
severe respiratory failure in acute respiratory distress syndrome.
Data Sources: We
searched the PubMed database for clinical trials, observational studies, and
review articles describing treatment adjuncts in acute respiratory distress
syndrome patients, including high positive end-expiratory pressure strategies,
recruitment maneuvers, high-frequency oscillatory ventilation, neuromuscular
blockade, prone positioning, inhaled pulmonary vasodilators, extracorporeal
membrane oxygenation, glucocorticoids, and renal replacement therapy.
Study Selection and Data Extraction: Results were reviewed by the primary author in
depth. Disputed findings and conclusions were then reviewed with the other
authors until consensus was achieved.
Data Synthesis:
Severe respiratory failure in acute respiratory distress syndrome may present
with refractory hypoxemia, severe respiratory acidosis, or elevated plateau
airway pressures despite lung-protective ventilation according to acute
respiratory distress syndrome Network protocol. For severe hypoxemia,
first-line treatment adjuncts include high positive end-expiratory pressure
strategies, recruitment maneuvers, neuromuscular blockade, and prone
positioning. For refractory acidosis, we recommend initial modest
liberalization of tidal volumes, followed by neuromuscular blockade and prone
positioning. For elevated plateau airway pressures, we suggest first decreasing
tidal volumes, followed by neuromuscular blockade, modification of positive
end-expiratory pressure, and prone positioning. Therapies such as inhaled
pulmonary vasodilators, glucocorticoids, and renal replacement therapy have
significantly less evidence in favor of their use and should be considered
second line. Extracorporeal membrane oxygenation may be life-saving in selected
patients with severe acute respiratory distress syndrome but should be used
only when other alternatives have been applied.
Conclusions:
Severe respiratory failure in acute respiratory distress syndrome often
necessitates the use of treatment adjuncts. Evidence-based application of these
therapies in acute respiratory distress syndrome remains a significant
challenge. However, a rational stepwise approach with frequent monitoring for
improvement or harm can be achieved.
No comments:
Post a Comment